T0	Interventions 14 58	prophylactic calcium and magnesium infusions
T1	Interventions 805 917	treatment with capecitabine, oxaliplatin and bevacizumab or the same combination with the addition of cetuximab.
T2	Interventions 961 1107	two groups: patients in the Ca/Mg(+) group received Ca/Mg at least during their first treatment cycle, and patients in the Ca/Mg(-) group did not.
T3	Interventions 1855 1869	neurotoxicity.
T4	Interventions 1870 1885	Ca/Mg infusions